Astermark J. , Bjorgell O., Linden E., Lethagen S., Nilsson P., Berntorp E.Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation . J Intern Med.1998;244:79-82.
2.
Ballantyne CS , Phillips SM, MacDonald JR, Tarnopolsky MA, MacDougall JDThe acute effects of androstenedione supplementation in healthy young males. Can J Appl Physiol.2000;25:68-78.
3.
Broeder CE, Quindry J., Brittingham K., et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med.2000;160:3093-3104.
4.
Buller HR, Giancarlo A., Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401-428.
5.
Carman T., Fernandez B.Issues and controversies in venous thromboembolism. Cleve Clin J Med.1999;66:113-123.
6.
DiFelice GS, Paletta GA, Phillips BB, Wright RWEffort thrombosis in the elite throwing athlete. Am J Sports Med.2002;30:708-712.
7.
Dugas J., Weiland A.Vascular pathology in the throwing athlete. Hand Clinics . 2000;16:477-485.
8.
Elman E., Kahn S.The postthrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res.2006 ;117:609-614.
9.
Hirsh J.Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis . Haemostasis. 1996;26(supplement 4):189-198.
10.
Hoibraaten E., Qvigstad E., Arnesen H., Larsen S., Wickstrom E., Sandset PMIncreased risk of recurrent venous thromboembolism during hormone replacement therapy: results of the randomized, double-blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET). Thromb Haemost.2000;84:961-967.
11.
Hughes ESR.Venous obstruction in the upper extremity (Paget-Schroetter syndrome): a review of 320 cases. Int Abstr Surg.1949;88: 84-127.
12.
Kahn SRFrequency and determinants of the postthrombotic syndrome after venous thromboembolism . Curr Opin Pulm Med.2006 ; 12:299-303.
13.
Kahn SR, Ginsberg J.The postthrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev.2002;16:155-165.
14.
King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA.1999;281:2020-2028.
15.
Meignan M., Rosso J., Gauthier H., et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep vein thrombosis. Arch Intern Med.2000;160:159-164.
16.
Nemmers D., Thorpe P., Knibbe M., Beard DWUpper extremity venous thrombosis: case report and literature review . Orthop Rev.1990;19: 164-172.
17.
Piatek LJLetter to the editor. Am J Sports Med.2003 ;31:636.
18.
Pinede L., Ninet J., Duhaut P., et al. Investigators of the “Duree Optimale du Traitement AntiVitamines K” (DOTAVK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001;103:2453-2460.
19.
Prandoni P. , Bernardi E.Upper extremity deep vein thrombosis . Curr Opin Pulm Med.1999;5:222-226.
20.
Savage K., Wells P., Schulz V., et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost.1999;82:1008-1010.
21.
Simonneau G. , Charbonnier B., Decousus H., et al. Subcutaneous lowmolecular—weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med.1993;153:1541-1546.
22.
Skerker RS, Flandry FCCase presentation: painless arm swelling in a high school football player . Med Sci Sports Exerc.1992;24:1185-1189.
23.
Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular—weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med.2003;163:1657-1663.
Tokish J., Kocher M., Hawkins R.Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med.2004 ;32:1543-1553.
26.
Zell L., Kindermann W., Marschall F., Scheffler P., Gross J., Buchter A.Paget-Schroetter syndrome in sports activities: case study and literature review. Angiology. 2001;52:337-342.
